Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Biotron Limited (ASX: BIT) - Share Price and Research
Current share price for BIT : $0.070 0.001 (1.41%)
Biotron Limited (BIT), an ASX-listed company, is involved in funding and management of intermediate and applied biotechnology research and development projects. Live Cell Imaging has been gaining extensive understanding and we have lined up comprehensive solutions to address this domain. This includes Confocal High Content, Holotomography, Imagers placed within CO2 Incubators and Imagers for Cell Line Development determining Proof of Monoclonality.
BIT General Information +
| ASX Code | BIT |
| Website | http://www.biotron.com.au |
| Industry/Sector | Biotechnology |
| Market Cap ($M) | 63 |
| BIT Share Price | $0.070 |
| Day High | $0.073 |
| Day Low | $0.070 |
| Last Close | $0.071 |
| BIT Share Price Movement | $0.00 ( 1.41% ) |
Prices as at 16:40, 19 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
BIT Related Research
Biotron Limited (BIT) Upcoming Dividends & Yields
There are no dividends for Biotron Limited (BIT). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Biotron Limited (BIT) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV | 5 Apr 2024 9:38AM | $0.075 | $0.070 | $0.075 | fallen by 6.67% |
| Response to ASX Price Query | 27 Mar 2024 9:05AM | $0.077 | $0.070 | $0.075 | fallen by 9.09% |
| Half Yearly Report and Accounts | 27 Feb 2024 9:06AM | $0.085 | $0.070 | $0.075 | fallen by 17.65% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Biotron Limited (BIT) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
BIT Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$3.49 | -$0.40 | 13.20% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$2.78 | -$0.40 | -13.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | -$3.19 | -$0.40 | -17.00% | 0.00 | 0.00 | 0.00% | 0.0% |
BIT Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| Biotron (BIT) | $64M | 0.1316 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| CSL (CSL) | $131,155M | -0.0712 | 0.1072 | 0.1864 | 39.7213 | 35.8757 | 30.2396 | 1.31% | 1.24% | 1.39% |
| Clinuvel Pharmaceuticals (CUV) | $766M | 0.4665 | 0.2049 | 0.1566 | 25.8714 | 21.4717 | 18.5648 | 0.33% | 0.46% | 0.52% |
| Mesoblast (MSB) | $885M | -0.1037 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Telix Pharmaceuticals (TLX) | $4,534M | -1.3767 | 0.0000 | 0.0000 | 108.7163 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
BIT Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 20.00 | 0.00 |
| Market | 0.53 | 15.00 | 1.10 | 1.00 |
| Sector | 1.26 | 21.10 | 1.96 | 0.95 |
BIT Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Michelle Miller | Managing Director | 21 Jun 2002 |
| Mr Robert Bain Thomas | Non-Executive Director | 7 Mar 2012 |
| Dr Susan Margaret Pond | Non-Executive Director | 7 Mar 2012 |
| Professor Stephen Alister Locarnini | Non-Executive Director | 23 Oct 2018 |
| Mr Michael J Hoy | Non-Executive Director, Non-Executive Chairman | 7 Feb 2000 |
Biotron Limited (BIT) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 25 Nov 2022 | THOMAS, Robert | Issued | Indirect Shares | 536,805 | $0.030 | $16,104.150 |
| 25 Nov 2022 | MILLER, Michelle | Issued | Indirect Shares | 300,000 | $0.030 | $9,000.000 |
| 25 Nov 2022 | MILLER, Michelle | Issued | Direct Shares | 331,250 | $0.057 | $18,937.500 |
See all changes in directors' interest & trades for Biotron Limited (BIT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
BIT Management
| Name | Position |
|---|---|
| Peter James Nightingale | Company Secretary |
BIT Calendar of Events
| Date | Event |
|---|---|
| 25 February 2025 | Report (Interim) |
| 18 October 2024 | Report (Annual) |
| 23 August 2024 | Report (Annual) |
| 23 August 2024 | Report (Prelim) |
FAQs about Biotron Limited (BIT)
What is the current share price of Biotron Limited (BIT)?
Biotron Limited's (BIT) current share price is $0.07. This constitutes a price movement of 6.67% when compared to the share price 7 days ago and is -41.67% below BIT's 12-month high of $0.12 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Biotron Limited (BIT)?
Relative to the previous close share price of $0.07, Biotron Limited's (BIT) current share price of $0.07 constitutes a movement of $0.00 or -1.41%. Biotron Limited's (BIT) share price movement is -6.67% when compared to 7 days ago and is -41.67% below BIT's 52-week high of $0.12.
What is the 52-week high share price for Biotron Limited (BIT)?
Biotron Limited's (BIT) 52-week high is $0.12 which was reached on 10 Nov 2023. Relative to this, BIT's current share price of $0.07 constitutes a -$0.05 or -41.67% drop since that high of $0.12 per BIT share.
What is the 52-week low share price for Biotron Limited (BIT)?
Biotron Limited's (BIT) 52-week low is $0.03 which was reached on 19 Jun 2023. Relative to this, BIT's current share price of $0.07 constitutes a $0.05 or 180% gain since that low of $0.03 per BIT share.
What is the daily average trading volume for Biotron Limited (BIT)?
Over the last 12 months, Biotron Limited (BIT) has a daily average trading volume of 3,299,680 BIT shares per day.
What is the dividend yield for Biotron Limited (BIT)?
Biotron Limited (BIT) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for BIT is a ratio that tells you the percentage of Biotron Limited's (BIT) share price that it pays out in dividends each year.
When does Biotron Limited (BIT) release its next Annual Report?
Biotron Limited (BIT) will release its next Annual Report on 18 October 2024. Biotron Limited's (BIT) last annual report was released on 20 Oct 2023. Click here to view Biotron Limited's (BIT) last annual report.
In which sector is Biotron Limited (BIT) classified?
Biotron Limited (BIT) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for Biotron Limited (BIT)?
The price-to-earnings (P/E) ratio for Biotron Limited (BIT) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Biotron Limited's (BIT) share price to its earnings per BIT share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
